Author:
Abt Dominik,Schmid Hans-Peter,Speakman Mark J.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Speakman MJ, Cornu JN, Gacci M et al (2019) What is the required certainty of evidence for the implementation of novel techniques for the treatment of benign prostatic obstruction? Eur Urol Focus 5(3):351–356. https://doi.org/10.1016/j.euf.2019.05.014
2. Emberton M, Marberger M, de la Rosette J (2008) Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: the prostate research on behaviour and education (PROBE) survey. Int J Clin Pract 62(1):18–26. https://doi.org/10.1111/j.1742-1241.2007.01635.x
3. Gravas S, Cornu JN, Gacci M, et al. (2020) EAU Guidelines on Management on Non-neurogenic Male LUTS. https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/.
4. McVary KT, Roehrborn CG, Avins AL, et al. American Urological Association Guideline: management of benign prostatic hyperplasia (BPH). Revised, 2010. https://www.auanet.org benign-prostatichyperplasia-(2010-reviewed-and-validity-confirmed-2014).
5. Thomas AW, Cannon A, Bartlett E et al (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction. BJU Int 96(9):1301–1306. https://doi.org/10.1111/j.1464-410X.2005.05815.x
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献